Concepedia

Claire Mason

CM

Statistics

Publications

5

Citations

1.4K

H-Index

5

Active since

2020

Affiliations

Royal Free London NHS Foundation Trust(Current)

Lancaster University

University of Oxford

Roslin Institute

Intensive Care National Audit & Research Centre

Claire Mason is an author at Royal Free London NHS Foundation Trust specializing in pharmacotherapy, 28-day mortality, and open-label trials.

Publications per year

2020–2023

5

Publications

5

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics

Claire Mason, Tanmay Kanitkar, Charlotte Richardson et al. · Journal of Antimicrobial Chemotherapy · 2020 · 50 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14

1–5 of 5